Marksans Pharma gains over 4% on Australian regulator’s nod for Goa facility

Marksans Pharma shares rose over 4% after its Goa plant secured Australian TGA approval for solid dosage forms. Its UK arm also received MHRA approval for Baclofen tablets yesterday.

Leave a Reply

Your email address will not be published. Required fields are marked *